In patients with severe community acquired pneumonia (CAP) does the use of hydrocortisone compared to a placebo reduce 28-day mortality?Continue reading »
In critically ill patients with septic shock, does the combination of hydrocortisone plus fludrocortisone therapy reduce 90 day mortality?Continue reading »
In critically ill patients with septic shock, does hydrocortisone compared with placebo, reduce 90 day mortality?Continue reading »
In patients with septic shock, do corticosteroids compared to placebo reduce mortality?
This is an editorial blog post in anticipation of the ADRENAL trial results to be presented at #CCR18.
In patients with septic shock who are treated with corticosteroids, does tight glycaemic control (4.44–6.1 mmol/l) compared with less-tight glycaemic control (<8.3 mmol/l) reduce in-hospital mortality?Continue reading »
In adults with a head injury, do early corticosteroids compared to placebo reduce death and disability?Continue reading »
Does a prolonged course of intravenous methylprednisolone improve lung function and reduce mortality in patients with unresolving ARDSContinue reading »
In patients with septic shock and relative adrenal deficiency does low dose corticosteroids improve 28 day mortality?Continue reading »
Is short-term (5 days) systemic glucocorticoid treatment in patients with COPD exacerbation as good as conventional (14 days) treatment in clinical outcome and does it decrease the overall exposure to steroids?Continue reading »
In patients in cardiac arrest, does vasopressin + epinephrine during CPR combined with steroid supplementation during and after CPR, improve survival to discharge with a good neurological outcome, in comparison to the use of epinephrine alone?Continue reading »